Yeqian Huang1,2,3, Ramesh Damodaran Prabha1, Terence C Chua4,5,6, Jennifer Arena1, Krishna Kotecha1, Anubhav Mittal1, Anthony J Gill2,7,8, Jaswinder S Samra1,9. 1. Department of Gastrointestinal Surgery, Royal North Shore Hospital, St Leonards, NSW, Australia. 2. Northern Clinical School, University of Sydney, Sydney, NSW, Australia. 3. South Western Clinical School, University of New South Wales, Sydney, NSW, Australia. 4. Department of Surgery, QE II Jubilee Hospital, Metro South Health, Brisbane, QLD, Australia. 5. School of Medicine, Griffith University, Gold Coast, QLD, Australia. 6. Discipline of Surgery, The University of Queensland, Brisbane, QLD, Australia. 7. Cancer Diagnosis and Pathology Group, Kolling Institute of Medical Research, St Leonards, NSW, Australia. 8. Deparment of Anatomical Pathology, Royal North Shore Hospital, St Leonards, NSW, Australia. 9. Macquarie University Hospital, Macquarie University, Sydney, NSW, Australia.
Abstract
Backgrounds: Pancreaticoduodenectomy (PD) remains the only hope of a cure in selected patients with pancreatic adenocarcinoma (PAC). With an aging population, there will be an increasing number of very elderly patients being diagnosed with PAC of whom a selected proportion would be suitable for PD. However, the literature on outcomes of elderly patients after PD remains ambiguous. Therefore, the aim of this study was to examine the safety and efficacy of PD in octogenarians with PAC. Methods: A retrospective analysis of 304 patients with PAC undergoing PD. Patients were divided into two age groups using age of 80 years old as the cut-off. Results: Overall mortality and major morbidity rates were 0.5 and 18.5%, respectively. The octogenarian group had a higher rate of mortality (6.3%, n = 1, p < 0.001), a higher rate of major morbidity (37.5%, n = 6, p = 0.042) and a longer hospital stay (p = 0.035). However, median survival of octogenarians was 15.6 months. Multivariate analysis showed age was not identified as a prognostic factor for major morbidity and overall survival. Conclusion: Age alone should not be an exclusion criterion for consideration of PD. With careful selection, PD can be safely performed in octogenarians. Elderly patients should be referred to a specialized unit for an objective assessment to determine the suitability for this aggressive but potential curative approach.
Backgrounds: Pancreaticoduodenectomy (PD) remains the only hope of a cure in selected patients with pancreatic adenocarcinoma (PAC). With an aging population, there will be an increasing number of very elderly patients being diagnosed with PAC of whom a selected proportion would be suitable for PD. However, the literature on outcomes of elderly patients after PD remains ambiguous. Therefore, the aim of this study was to examine the safety and efficacy of PD in octogenarians with PAC. Methods: A retrospective analysis of 304 patients with PAC undergoing PD. Patients were divided into two age groups using age of 80 years old as the cut-off. Results: Overall mortality and major morbidity rates were 0.5 and 18.5%, respectively. The octogenarian group had a higher rate of mortality (6.3%, n = 1, p < 0.001), a higher rate of major morbidity (37.5%, n = 6, p = 0.042) and a longer hospital stay (p = 0.035). However, median survival of octogenarians was 15.6 months. Multivariate analysis showed age was not identified as a prognostic factor for major morbidity and overall survival. Conclusion:Age alone should not be an exclusion criterion for consideration of PD. With careful selection, PD can be safely performed in octogenarians. Elderly patients should be referred to a specialized unit for an objective assessment to determine the suitability for this aggressive but potential curative approach.
Authors: Thijs de Rooij; Marc G Besselink; Awad Shamali; Giovanni Butturini; Olivier R Busch; Bjørn Edwin; Roberto Troisi; Laureano Fernández-Cruz; Ibrahim Dagher; Claudio Bassi; Mohammad Abu Hilal Journal: HPB (Oxford) Date: 2015-12-10 Impact factor: 3.647
Authors: Martin A Makary; Jordan M Winter; John L Cameron; Kurtis A Campbell; David Chang; Steven C Cunningham; Taylor S Riall; Charles J Yeo Journal: J Gastrointest Surg Date: 2006-03 Impact factor: 3.452
Authors: Saboor Khan; Guido Sclabas; Kaye Reid Lombardo; Michael G Sarr; David Nagorney; Michael L Kendrick; John H Donohue; Florencia G Que; Michael B Farnell Journal: J Gastrointest Surg Date: 2010-08-17 Impact factor: 3.452
Authors: Jordan M Winter; John L Cameron; Charles J Yeo; Babatunde Alao; Keith D Lillemoe; Kurtis A Campbell; Richard D Schulick Journal: J Am Coll Surg Date: 2007-03-27 Impact factor: 6.113
Authors: J W T Dekker; C B M van den Broek; E Bastiaannet; L G M van de Geest; R A E M Tollenaar; G J Liefers Journal: Ann Surg Oncol Date: 2011-03-29 Impact factor: 5.344
Authors: Sean E Kisch; Elizabeth R Nussbaum; M Alyssa Varsanik; Alexander O'Hara; Jacob J Pozin; Michael J Littau; Xuanji Wang; Erin Carollo; Lawrence M Knab; Gerard Abood Journal: Surg Open Sci Date: 2021-12-04